Stay updated on Atezolizumab Combo in Untreated Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab Combo in Untreated Lung Cancer Clinical Trial page.

Latest updates to the Atezolizumab Combo in Untreated Lung Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check22 days agoChange DetectedA site-wide NIH notice announces a transition from using “Artificial Intelligence” to “Super Intelligence” terminology.SummaryDifference0.4%

- Check29 days agoChange DetectedThe footer’s ClinicalTrials.gov revision number changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check36 days agoChange DetectedThe site footer revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check57 days agoChange DetectedA new revision label v3.7.0 was added to the history and the previous revision label v3.6.6 was removed.SummaryDifference0.1%

- Check78 days agoChange DetectedAn entry in the study record history shows Revision: v3.6.6 replacing the previous v3.6.5, indicating a software revision applied to the page history.SummaryDifference0.1%

Stay in the know with updates to Atezolizumab Combo in Untreated Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab Combo in Untreated Lung Cancer Clinical Trial page.